glp 1 clinical trials recruiting GLP-1a: Going beyond Traditional Use Targeting GLP-1 receptor trafficking to

Only 34% of GLP-1 patients on DPP-4 inhibitors, a class of oral diabetic medications also known as gliptins, were still taking DPP-4 inhibitors 52 weeks after starting GLP-1 therapy according to Earnest pharmacy claims data

And if you havent yet begun an education in nutrition and dietetics, theres a strong likelihood that GLP-1 training will be part and parcel of future nutrition programs

doi: 10.1016/S0140-6736(24)00469-0

Saxenda and Gastroparesis: Studies Link Liraglutide to Stomach Paralysis Research, including recent studies, has linked liraglutide to serious gastrointestinal issues, including gastroparesis or paralysis of the stomach